This is a report of a patient with chronic progressive eosinophilic fasciitis over at least a 20-year period. Serial myofascial biopsies and creatine excretion showed active disease over the entire span in spite of steroid therapy. The Twenty years ago he was admitted to hospital because of aching pain in all extremities for 3 months and recurrent urticaria for 3 weeks. All the muscles were tender, but their strength, motion, and mass were normal. Several urticarial patches marked the thorax and face as well as the limbs. The scrotum and perianal region showed vitiligo.
The peripheral eosinophil count was 3200 per mm3 (3-2 x 109/l); the sedimentation rate 14 mm in 1 h; the globulin fraction 3 2 gIdl (32 g/l); the albumin 3 3 g/dl (33 g/l); rheumatoid factor and LE cell determinations negative; and the SGOT 44 units (normal 5-40 units). Muscle biopsy showed profound mononuclear and eosinophilic infiltrate of the fascial and subcutaneous layers. Muscular septa contained modest focal accumulations of eosinophils, more prominent in areas adjacent to the fascia. Myonal necrosis was absent. The epidermis was normal. The pathological diagnosis was 'anaphylactoid myositis. ' The patient developed fevers, progressive weight loss, and stiff, swollen hands. Transient crops of urticaria recurred. All these symptoms improved on prednisone 5 A fourth muscle biopsy again showed profound inflammatory fascial thickening with mild, focal, non-necrotising myositis. The clinical diagnosis was now dermatomyositis. Skin changes were regarded as insufficient for the diagnosis of scleroderma.
Three years ago prednisone was-slowly withdrawn. Enteric-coated aspirin was given in therapeutic dosage for arthralgias. Contractures and muscle atrophy in all limbs and digits were evident, but the skin, while taut to palpation, visually appeared normal.
One year ago the patient was admitted to the hospital because of marked increase in skin thickening and contractures. The skin ranged from woody to rockhard in consistency, with broad areas of lumpy sur- This case clearly makes the point that eosinophilic fasciitis can be extensive, chronic, and irreversibly disabling. It also focuses attention on the difficulty of evaluating disease activity. We recognise 4 general areas in the assessment of disease activity: acute phase (eosinophilia, elevated acute phase reactants, hypergammaglobulinaemia); skin thickening and contracture; muscle atrophy; and histological changes.
Acute phase changes usually subside in the first year or two of illness, whether or not the skin changes resolve completely. In this patient eosinophilia disappeared within 6 months of onset. The ESR varied widely thereafter but was not clearly related to disease activity. It was normal at the onset of the disease and during most of the last 3 years of the case record, times at which muscle biopsies showed marked fasciitis. Moderate polyclonal hypergammaglobulinaemia persisted throughout the illness, almost as a fixed serological abnormality. Episodes of depressed cryoglobulins and complement were absent.
Fascial thickening is the hallmark of the disease, but no objective measurement of it has been proposed. The weight of 7 mm skin thickness cores, as is used to evaluate scleroderma, was increased in 5 
